The importance of immune dysfunction in determining outcome in acute liver failure

Journal of Hepatology

Volumn 49, Issue 5, 2008, Pages 845-861

  Antoniades, Charalambos Gustav ^a   Berry, Philip A ^a   Wendon, Julia A ^a   Vergani, Diego ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Acute liver failure; Compensatory anti inflammatory response; Monocyte HLA DR; Monocytes macrophages; Multiple organ dysfunction syndrome; Systemic inflammatory response

Indexed keywords

CYTOKINE; FAS LIGAND; FIBRONECTIN; HLA DR ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; CELL DEATH; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; EFFECTOR CELL; ENDOTHELIUM CELL; EX VIVO STUDY; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; INNATE IMMUNITY; KUPFFER CELL; LIVER CELL; LIVER FAILURE; LIVER INJURY; LIVER REGENERATION; LIVER SINUSOID; MULTIPLE ORGAN FAILURE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SEPSIS;

APOPTOSIS; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; FIBRONECTINS; HLA-DR ANTIGENS; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; KUPFFER CELLS; LIVER FAILURE, ACUTE; MACROPHAGES; MODELS, IMMUNOLOGICAL; MONOCYTES; MULTIPLE ORGAN FAILURE; NATURAL KILLER T-CELLS; NEUTROPHILS; PROGNOSIS; SEPSIS; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 53249087835     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.08.009     Document Type: Review

References (187)

1. Rolando N., Wade J., Davalos M., Wendon J., Philpott-Howard J., and Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 32 (2000) 734-739
2. Vaquero J., Polson J., Chung C., Helenowski I., Schiodt F.V., Reisch J., et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 125 (2003) 755-764
3. Trewby P.N., and Williams R. Pathophysiology of hypotension in patients with fulminant hepatic failure. Gut 18 (1977) 1021-1026
4. Schmidt L.E., and Larsen F.S. Prognostic implications of hyperlactataemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure. Crit Care Med 34 (2006) 337-343
5. Rolando N., Harvey F., Brahm J., Philpott-Howard J., Alexander G., Gimson A., et al. Prospective study of bacterial infection in acute liver failure: an analysis of 50 patients. Hepatology 11 (1990) 49-53
6. Lee W.M. Acute liver failure. Am J Med 96 (1994) 3S-9S
7. Harry R., Auzinger G., and Wendon J. The effects of supraphysiological doses of corticosteroids in hypotensive liver failure. Liver Int 23 (2003) 71-77
8. Harry R., Auzinger G., and Wendon J. The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology 36 (2002) 395-402
9. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 (1992) 1644-1655
10. Bone R.C., Sibbald W.J., and Sprung C.L. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 101 (1992) 1481-1483
11. Bone R.C., Grodzin C.J., and Balk R.A. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112 (1997) 235-243
12. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 26 (2000) S64-S74
13. Nystrom P.O. The systemic inflammatory response syndrome: definitions and aetiology. J Antimicrob Chemother 41 (1998) 1-7
14. Takala A., Nupponen I., Kylanpaa-Back M.L., and Repo H. Markers of inflammation in sepsis. Ann Med 34 (2002) 614-623
15. Talmor M., Hydo L., and Barie P.S. Relationship of systemic inflammatory response syndrome to organ dysfunction, length of stay, and mortality in critical surgical illness: effect of intensive care unit resuscitation. Arch Surg 134 (1999) 81-87
16. Pittet D., Rangel-Frausto S., Li N., Tarara D., Costigan M., Rempe L., et al. Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med 21 (1995) 302-309
17. Rodriguez-Gaspar M., Santolaria F., Jarque-Lopez A., Gonzalez-Reimers E., Milena A., de la Vega M.J., et al. Prognostic value of cytokines in SIRS general medical patients. Cytokine 15 (2001) 232-236
18. Calandra T., Baumgartner J.D., Grau G.E., Wu M.M., Lambert P.H., Schellekens J., et al. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis 161 (1990) 982-987
19. Calandra T., Gerain J., Heumann D., Baumgartner J.D., and Glauser M.P. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am J Med 91 (1991) 23-29
20. Martin C., Boisson C., Haccoun M., Thomachot L., and Mege J.L. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 25 (1997) 1813-1819
21. Martin C., Saux P., Mege J.L., Perrin G., Papazian L., and Gouin F. Prognostic values of serum cytokines in septic shock. Intensive Care Med 20 (1994) 272-277
22. Friedman G., Jankowski S., Marchant A., Goldman M., Kahn R.J., and Vincent J.L. Blood interleukin 10 levels parallel the severity of septic shock. J Crit Care 12 (1997) 183-187
23. Lehmann A.K., Halstensen A., and Sornes S. High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. Infect Immun 63 (1995) 2109-2112
24. Marchant A., Alegre M.L., and Hakim A. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J Clin Immunol 15 (1995) 266-273
25. Kox W.J., Volk T., Kox S.N., and Volk H.D. Immunomodulatory therapies in sepsis. Intensive Care Med 26 (2000) S124-S128
26. Riordan F.A., Marzouk O., Thomson A.P., Sills J.A., and Hart C.A. Proinflammatory and anti-inflammatory cytokines in meningococcal disease. Arch Dis Child 75 (1996) 453-454
27. van Deuren M., van der Ven-Jongekrijg J., Bartelink A.K., van Dalen R., Sauerwein R.W., and van der Meer J.W. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis 172 (1995) 433-439
28. Docke W.D., Randow F., Syrbe U., Krausch D., Asadullah K., Reinke P., et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 3 (1997) 678-681
29. West M.A., and Heagy W. Endotoxin tolerance: a review. Crit Care Med 30 (2002) S64-S73
30. Heagy W., Hansen C., Nieman K., Rodriguez J.L., and West M.A. Impaired mitogen-activated protein kinase activation and altered cytokine secretion in endotoxin-tolerant human monocytes. J Trauma 49 (2000) 806-814
31. Ziegler-Heitbrock H.W., Blumenstein M., Kafferlein E., Kieper D., Petersmann I., Endres S., et al. In vitro desensitization to lipopolysaccharide suppresses tumour necrosis factor, interleukin-1 and interleukin-6 gene expression in a similar fashion. Immunology 75 (1992) 264-268
32. Kaufmann A., Gemsa D., and Sprenger H. Differential desensitization of lipopolysaccharide-inducible chemokine gene expression in human monocytes and macrophages. Eur J Immunol 30 (2000) 1562-1567
33. Ogata M., Okamoto K., Kohriyama K., Kawasaki T., Itoh H., and Shigematsu A. Role of interleukin-10 on hyporesponsiveness of endotoxin during surgery. Crit Care Med 28 (2000) 3166-3170
34. Sfeir T., Saha D.C., Astiz M., and Rackow E.C. Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med 29 (2001) 129-133
35. Wolk K., Docke W.D., von Baehr V., Volk H.D., and Sabat R. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 96 (2000) 218-223
36. Le Tulzo Y., Shenkar R., Kaneko D., Moine P., Fantuzzi G., Dinarello C.A., et al. Hemorrhage increases cytokine expression in lung mononuclear cells in mice: involvement of catecholamines in nuclear factor-kappaB regulation and cytokine expression. J Clin Invest 99 (1997) 1516-1524
37. Volk T., Döpfmer U.R., Schmutzler M., Rimpau S., Schnitzler H., Konertz W., et al. Stress induced IL-10 does not seem to be essential for early monocyte deactivation following cardiac surgery. Cytokine 24 (2003) 237-243
38. Asadullah K., Woiciechowsky C., Docke W.D., Egerer K., Kox W.J., Vogel S., et al. Very low monocytic HLA-DR expression indicates high risk of infection - immunomonitoring for patients after neurosurgery and patients during high dose steroid therapy. Eur J Emerg Med 2 (1995) 184-190
39. Fillinger M.P., Rassias A.J., Guyre P.M., Sanders J.H., Beach M., Pahl J., et al. Glucocorticoid effects on the inflammatory and clinical responses to cardiac surgery. J Cardiothorac Vasc Anesth 16 (2002) 163-169
40. Haveman J.W., van den Berg A.P., van den Berk J.M., Mesander G., Slooff M.J., de Leij L.H., et al. Low HLA-DR expression on peripheral blood monocytes predicts bacterial sepsis after liver transplantation: relation with prednisolone intake. Transpl Infect Dis 1 (1999) 146-152
41. Le Tulzo Y., Pangault C., Amiot L., Guilloux V., Tribut O., Arvieux C., et al. Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock. Am J Respir Crit Care Med 169 (2004) 1144-1151
42. Volk T., Schmutzler M., Engelhardt L., Docke W.D., Volk H.D., Konertz W., et al. Influence of aminosteroid and glucocorticoid treatment on inflammation and immune function during cardiopulmonary bypass. Crit Care Med 29 (2001) 2137-2142
43. Schwiebert L.M., Schleimer R.P., Radka S.F., and Ono S.J. Modulation of MHC class II expression in human cells by dexamethasone. Cell Immunol 165 (1995) 12-19
44. Fumeaux T., and Pugin J. Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am J Respir Crit Care Med 166 (2002) 1475-1482
45. Hynninen M., Pettila V., Takkunen O., Orko R., Jansson S.E., Kuusela P., et al. Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis. Shock 20 (2003) 1-4
46. Monneret G., Finck M.E., Venet F., Debard A.L., Bohe J., Bienvenu J., et al. The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 95 (2004) 193-198
47. Perry S.E., Mostafa S.M., Wenstone R., Shenkin A., and McLaughlin P.J. Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis?. Intensive Care Med 29 (2003) 1245-1252
48. Tschaikowsky K., Hedwig-Geissing M., Schiele A., Bremer F., Schywalsky M., and Schuttler J. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med 30 (2002) 1015-1023
49. Flohe S., Lendemans S., Selbach C., Waydhas C., Ackermann M., Schade F.U., et al. Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma. Crit Care Med 31 (2003) 2462-2469
50. Hershman M.J., Cheadle W.G., Wellhausen S.R., Davidson P.F., and Polk Jr. H.C. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 77 (1990) 204-207
51. Nierhaus A., Montag B., Timmler N., Frings D.P., Gutensohn K., Jung R., et al. Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Med 29 (2003) 646-651
52. Oczenski W., Krenn H., Jilch R., Watzka H., Waldenberger F., Koller U., et al. HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery. Intensive Care Med 29 (2003) 1253-1257
53. Osuchowski M.F., Welch K., Siddiqui J., and Remick D.G. Circulating cytokine/inhibitor profiles reschape continuum in sepsis and predict mortality. J Immunol 177 (2006) 1967-1974
54. Barsig J., Kusters S., Vogt K., Volk H.D., Tiegs G., and Wendel A. Lipopolysaccharide-induced interleukin-10 in mice. role of endogenous tumor necrosis factor-alpha. Eur J Immunol 25 (1995) 2888-2893
55. Kuhns D.B., Alvord W.G., and Gallin J.I. Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J Infect Dis 171 (1995) 145-152
56. Ozbalkan Z., Aslar A.K., Yildiz Y., and Aksaray S. Investigation of the course of proinflammatory and anti-inflammatory cytokines after burn sepsis. Int J Clin Pract 58 (2004) 125-129
57. Wolk K., Docke W., von Baehr V., Volk H., and Sabat R. Comparison of monocyte functions after LPS- or IL-10-induced reorientation: importance in clinical immunoparalysis. Pathobiology 67 (1999) 253-256
58. Yeh F.L., Lin W.L., and Shen H.D. Changes in circulating levels of an anti-inflammatory cytokine interleukin 10 in burned patients. Burns 26 (2000) 454-459
59. van Dissel J.T., van Langevelde P., Westendorp R.G., Kwappenberg K., and Frolich M. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 351 (1998) 950-953
60. Torre D., Tambini R., Aristodemo S., Gavazzeni G., Goglio A., Cantamessa C., et al. Anti-inflammatory response of IL-4, IL-10 and TGF-beta in patients with systemic inflammatory response syndrome. Mediators Inflamm 9 (2000) 193-195
61. Warwick-Davies J., Lowrie D.B., and Cole P.J. Selective deactivation of human monocyte functions by TGF-beta. J Immunol 155 (1995) 3186-3193
62. Lawrence T., Gilroy D.W., Colville-Nash P.R., and Willoughby D.A. Possible new role for NF-kappaB in the resolution of inflammation. Nat Med 7 (2001) 1291-1297
63. Musiek E.S., Gao L., Milne G.L., Han W., Everhart M.B., Wang D., et al. Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages. J Biol Chem 280 (2005) 35562-35570
64. Zingarelli B., and Cook J.A. Peroxisome proliferator-activated receptor-gamma is a new therapeutic target in sepsis and inflammation. Shock 23 (2005) 393-399
65. Collin M., Patel N.S., Dugo L., and Thiemermann C. Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15-deoxydelta12, 14 prostaglandin J2 against the multiple organ failure caused by endotoxin. Crit Care Med 32 (2004) 826-831
66. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., and Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5 (1999) 698-701
67. Hortelano S., Castrillo A., Alvarez A.M., and Bosca L. Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages. J Immunol 165 (2000) 6525-6531
68. Lawrence T., Bebien M., Liu G.Y., Nizet V., and Karin M. IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature 434 (2005) 1138-1143
69. de la Mata M., Meager A., Rolando N., Daniels H.M., Nouri-Aria K.T., Goka A.K., et al. Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection. Clin Exp Immunol 82 (1990) 479-484
70. Wigmore S.J., Walsh T.S., Lee A., and Ross J.A. Pro-inflammatory cytokine release and mediation of the acute phase protein response in fulminant hepatic failure. Intensive Care Med 24 (1998) 224-229
71. Antoniades C.G., Berry P.A., Davies E.T., Hussain M., Bernal W., Vergani D., et al. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 44 (2006) 34-43
72. Antoniades C.G., PA B., Longhi S., Davies E.T., Cross T.J., Hussain M., et al. IL-10 producing monocytes in acute liver failure: correlation with systemic inflammatory response. Hepatology 44 (2006) 364A
73. Antoniades C.G., PA B., Carey I., Scalori A., Wendon J., and Vergani D. Evidence of endotoxin tolerance and severely impaired T-helper 1 response in acute hepatic failure. Hepatology 46 (2007) 614A
74. Loercher A.E., Nash M.A., Kavanagh J.J., Platsoucas C.D., and Freedman R.S. Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells. J Immunol 163 (1999) 6251-6260
75. Wyke R.J., Rajkovic I.A., Eddleston A.L., and Williams R. Defective opsonisation and complement deficiency in serum from patients with fulminant hepatic failure. Gut 21 (1980) 643-649
76. Wyke R.J., Yousif-Kadaru A.G., Rajkovic I.A., Eddleston A.L., and Williams R. Serum stimulatory activity and polymorphonuclear leucocyte movement in patients with fulminant hepatic failure. Clin Exp Immunol 50 (1982) 442-449
77. Canalese J., Wyke R.J., Vergani D., Eddleston A.L., and Williams R. Circulating immune complexes in patients with fulminant hepatic failure. Gut 22 (1981) 845-848
78. Clapperton M., Rolando N., Sandoval L., Davies E., and Williams R. Neutrophil superoxide and hydrogen peroxide production in patients with acute liver failure. Eur J Clin Invest 27 (1997) 164-168
79. Rolando N., Clapperton M., Wade J., Panetsos G., Mufti G., and Williams R. Granulocyte colony-stimulating factor improves function of neutrophils from patients with acute liver failure. Eur J Gastroenterol Hepatol 12 (2000) 1135-1140
80. Rolando N., Clapperton M., Wade J., and Wendon J. Administering granulocyte colony-stimulating factor to acute liver failure patients corrects neutrophil defects. Eur J Gastroenterol Hepatol 12 (2000) 1323-1328
81. Imawari M., Huges R.D., Gove C.D., and Williams R. Fibronectin and kupffer cell function in fulminant hepatic failure. Dig Dis Sci 30 (1985) 1028-1033
82. Acharya S.K., Dasarathy S., and Irshad M. Prospective study of plasma fibronectin in fulminant hepatitis: association with infection and mortality. J Hepatol 23 (1995) 8-13
83. Anand A.C., Irshad M., Acharya S.K., Gandhi B.M., Joshi Y.K., and Tandon B.N. Fibronectin in acute and subacute hepatic failure. J Clin Gastroenterol 11 (1989) 314-319
84. Cressman D.E., Greenbaum L.E., DeAngelis R.A., Ciliberto G., Furth E.E., Poli V., et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274 (1996) 1379-1383
85. Fausto N., Campbell J.S., and Riehle K.J. Liver regeneration. Hepatology 43 (2006) S45-S53
86. Simpson K.J. Cytokines, for better or worse?. Eur J Gastroenterol Hepatol 11 (1999) 957-966
87. Arai T., Hiromatsu K., Kobayashi N., Takano M., Ishida H., Nimura Y., et al. IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury. J Immunol 155 (1995) 5743-5749
88. Gazzinelli R.T., Wysocka M., Hieny S., Scharton-Kersten T., Cheever A., Kühn R., et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol 157 (1996) 798-805
89. Louis H., Le Moine A., Quertinmont E., Peny M.O., Geerts A., Goldman M., et al. Repeated concanavalin A challenge in mice induces an interleukin 10-producing phenotype and liver fibrosis. Hepatology 31 (2000) 381-390
90. Louis H., Le Moine O., Goldman M., and Deviere J. Modulation of liver injury by interleukin-10. Acta Gastroenterol Belg 66 (2003) 7-14
91. Louis H., Le Moine O., Peny M.O., Gulbis B., Nisol F., Goldman M., et al. Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury. Gastroenterology 112 (1997) 935-942
92. Louis H., Le Moine O., Peny M.O., Quertinmont E., Fokan D., Goldman M., et al. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice. Hepatology 25 (1997) 1382-1389
93. Louis H., Van Laethem J.L., Wu W., Quertinmont E., Degraef C., Van den Berg K., et al. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 28 (1998) 1607-1615
94. Nagaki M., Iwai H., Naiki T., Ohnishi H., Muto Y., and Moriwaki H. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis. J Infect Dis 182 (2000) 1103-1108
95. Bourdi M., Masubuchi Y., Reilly T.P., Amouzadeh H.R., Martin J.L., George J.W., et al. Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 35 (2002) 289-298
96. Muto Y., Nouri-Aria K.T., Meager A., Alexander G.J., Eddleston A.L., and Williams R. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 2 (1988) 72-74
97. Yumoto E., Higashi T., Nouso K., Nakatsukasa H., Fujiwara K., Hanafusa T., et al. Serum gamma-interferon-inducing factor (IL-18) and IL-10 levels in patients with acute hepatitis and fulminant hepatic failure. J Gastroenterol Hepatol 17 (2002) 285-294
98. Streetz K., Leifeld L., Grundmann D., Ramakers J., Eckert K., Spengler U., et al. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 119 (2000) 446-460
99. Sekiyama K.D., Yoshiba M., and Thomson A.W. Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol 98 (1994) 71-77
100. Sheron N., Keane H., Goka J., Alexander G., Williams R., and Wendon J. Circulating acute phase cytokines and cytokine inhibitors in fulminant hepatic failure: associations with mortality and haemodynamics. Clin Intensive Care 12 (2001) 127-134
101. Izumi S., Hughes R.D., Langley P.G., Pernambuco J.R., and Williams R. Extent of the acute phase response in fulminant hepatic failure. Gut 35 (1994) 982-986
102. Nakao A., Taki S., Yasui M., Kimura Y., Nonami T., Harada A., et al. The fate of intravenously injected endotoxin in normal rats and in rats with liver failure. Hepatology 19 (1994) 1251-1256
103. Nolan J. The role of endotoxin in liver injury. Gastroenterology 69 (1975) 1346-1356
104. Canalese J., Gove C.D., Gimson A.E., Wilkinson S.P., Wardle E.N., and Williams R. Reticuloendothelial system and hepatocytic function in fulminant hepatic failure. Gut 23 (1982) 265-269
105. Laskin D.L., Pilaro A.M., and Ji S. Potential role of activated macrophages in acetaminophen hepatotoxicity. II. Mechanism of macrophage accumulation and activation. Toxicol Appl Pharmacol 86 (1986) 216-226
106. Michael S.L., Pumford N.R., Mayeux P.R., Niesman M.R., and Hinson J.A. Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology 30 (1999) 186-195
107. Schumann J., Wolf D., Pahl A., Brune K., Papadopoulos T., van Rooijen N., et al. Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol 157 (2000) 1671-1683
108. Tsung A., Hoffman R.A., Izuishi K., Critchlow N.D., Nakao A., Chan M.H., et al. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 175 (2005) 7661-7668
109. Andres D., Sanchez-Reus I., Bautista M., and Cascales M. Depletion of Kupffer cell function by gadolinium chloride attenuates thioacetamide-induced hepatotoxicity. Expression of metallothionein and HSP70. Biochem Pharmacol 66 (2003) 917-926
110. Knolle P., Schlaak J., Uhrig A., Kempf P., Meyer zum Buschenfelde K.H., and Gerken G. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol 22 (1995) 226-229
111. Knolle P.A., Loser E., Protzer U., Duchmann R., Schmitt E., zum Buschenfelde K.H., et al. Regulation of endotoxin-induced IL-6 production in liver sinusoidal endothelial cells and Kupffer cells by IL-10. Clin Exp Immunol 107 (1997) 555-561
112. Grewe M., Duyster J., Dieter P., Henninger H., Schulze-Specking A., and Decker K. Prostaglandin D2 and E2 syntheses in rat Kupffer cells are antagonistically regulated by lipopolysaccharide and phorbol ester. Biol Chem Hoppe Seyler 373 (1992) 655-664
113. Bissell D.M., Wang S.S., Jarnagin W.R., and Roll F.J. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 96 (1995) 447-455
114. Knolle P.A., and Gerken G. Local control of the immune response in the liver. Immunol Rev 174 (2000) 21-34
115. Knolle P.A., Uhrig A., Hegenbarth S., Loser E., Schmitt E., Gerken G., et al. IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules. Clin Exp Immunol 114 (1998) 427-433
116. Nagaki M., Muto Y., Ohnishi H., Yasuda S., Sano K., and Naito T. Hepatic injury and lethal shock in galactosamine-sensitized mice induced by superantigen staphylococcal enterotoxin B. Gastroenterology 106 (1994) 450-458
117. Nagaki M., Tanaka M., Sugiyama A., Ohnishi H., and Moriwaki H. Interleukin-10 inhibits hepatic injury and tumor necrosis factor-alpha and interferon-gamma mRNA expression induced by staphylococcal enterotoxin B or lipopolysaccharide in galactosamine-sensitized mice. J Hepatol 31 (1999) 815-824
118. Nishinuma I., Nagakawa J., Miyamoto K., Tsukidate K., Yamanaka T., and Katayama K. Involvement of tumor necrosis factor-alpha in development of hepatic injury in galactosamine-sensitized mice. Hepatology 12 (1990) 1187-1191
119. Rudiger H.A., and Clavien P.-A. Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischaemic liver. Gastroenterology 122 (2002) 202-210
120. Gantner F., Leist M., Lohse A.W., Germann P.G., and Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21 (1995) 190-198
121. Kusters S., Gantner F., Kunstle G., and Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 111 (1996) 462-471
122. Jaruga B., Hong F., Kim W.H., and Gao B. IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. Am J Physiol Gastrointest Liver Physiol 287 (2004) G1044-G1052
123. Ishida Y., Kondo T., Ohshima T., Fujiwara H., Iwakura Y., and Mukaida N. A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J 16 (2002) 1227-1236
124. Jaeschke H., and Smith C.W. Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol 61 (1997) 647-653
125. Dambach D.M., Watson L.M., Gray K.R., Durham S.K., and Laskin D.L. Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology 35 (2002) 1093-1103
126. Roberts R.A., Ganey P.E., Ju C., Kamendulis L.M., Rusyn I., and Klaunig J.E. Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci 96 (2007) 2-15
127. Ju C., Reilly T.P., Bourdi M., Radonovich M.F., Brady J.N., George J.W., et al. Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. Chem Res Toxicol 15 (2002) 1504-1513
128. Prins H.A., Meijer C., Boelens P.G., Diks J., Holtz R., Masson S., et al. Kupffer cell-depleted rats have a diminished acute-phase response following major liver resection. Shock 21 (2004) 561-565
129. Liu Z.X., Govindarajan S., and Kaplowitz N. Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 127 (2004) 1760-1774
130. Takeda K., Hayakawa Y., Van Kaer L., Matsuda H., Yagita H., and Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 97 (2000) 5498-5503
131. Louis H., Le Moine A., Flamand V., Nagy N., Quertinmont E., Paulart F., et al. Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice. Gastroenterology 122 (2002) 2001-2010
132. Dong Z., Wei H., Sun R., Hu Z., Gao B., and Tian Z. Involvement of natural killer cells in PolyI:C-induced liver injury. J Hepatol 41 (2004) 966-973
133. Sivori S., Falco M., Della Chiesa M., Carlomagno S., Vitale M., Moretta L., et al. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 101 (2004) 10116-10121
134. Ochi M., Ohdan H., Mitsuta H., Onoe T., Tokita D., Hara H., et al. Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice. Hepatology 39 (2004) 1321-1331
135. Bajt M.L., Farhood A., and Jaeschke H. Effects of CXC chemokines on neutrophil activation and sequestration in hepatic vasculature. Am J Physiol Gastrointest Liver Physiol 281 (2001) G1188-G1195
136. Bautista A.P., and Spitzer J.J. Platelet activating factor stimulates and primes the liver, Kupffer cells and neutrophils to release superoxide anion. Free Radic Res Commun 17 (1992) 195-209
137. Schlayer H.J., Laaff H., Peters T., Woort-Menker M., Estler H.C., Karck U., et al. Involvement of tumor necrosis factor in endotoxin-triggered neutrophil adherence to sinusoidal endothelial cells of mouse liver and its modulation in acute phase. J Hepatol 7 (1988) 239-249
138. Witthaut R., Farhood A., Smith C.W., and Jaeschke H. Complement and tumor necrosis factor-alpha contribute to Mac-1 (CD11b/CD18) up-regulation and systemic neutrophil activation during endotoxemia in vivo. J Leukoc Biol 55 (1994) 105-111
139. Jaeschke H., Farhood A., Bautista A.P., Spolarics Z., and Spitzer J.J. Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am J Physiol 264 (1993) G801-G809
140. Curzio M., Esterbauer H., Di Mauro C., Cecchini G., and Dianzani M.U. Chemotactic activity of the lipid peroxidation product 4-hydroxynonenal and homologous hydroxyalkenals. Biol Chem Hoppe Seyler 367 (1986) 321-329
141. Scaffidi P., Misteli T., and Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418 (2002) 191-195
142. Ramaiah S.K., and Jaeschke H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol 35 (2007) 757-766
143. Jaeschke H., and Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 260 (1991) G355-G362
144. Jaeschke H., Farhood A., and Smith C.W. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 4 (1990) 3355-3359
145. Jaeschke H., Farhood A., and Smith C.W. Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am J Physiol 261 (1991) G1051-G1056
146. Luyendyk J.P., Shaw P.J., Green C.D., Maddox J.F., Ganey P.E., and Roth R.A. Coagulation-mediated hypoxia and neutrophil-dependent hepatic injury in rats given lipopolysaccharide and ranitidine. J Pharmacol Exp Ther 314 (2005) 1023-1031
147. Bonder C.S., Ajuebor M.N., Zbytnuik L.D., Kubes P., and Swain M.G. Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis. J Immunol 172 (2004) 45-53
148. Rieder H., Ramadori G., Allmann K.H., and Meyer zum Buschenfelde K.H. Prostanoid release of cultured liver sinusoidal endothelial cells in response to endotoxin and tumor necrosis factor. Comparison with umbilical vein endothelial cells. J Hepatol 11 (1990) 359-366
149. Knolle P.A., Germann T., Treichel U., Uhrig A., Schmitt E., Hegenbarth S., et al. Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells. J Immunol 162 (1999) 1401-1407
150. Lawson J.A., Burns A.R., Farhood A., Lynn Bajt M., Collins R.G., Smith C.W., et al. Pathophysiologic importance of E- and L-selectin for neutrophil-induced liver injury during endotoxemia in mice. Hepatology 32 (2000) 990-998
151. Takenaka K., Sakaida I., Yasunaga M., and Okita K. Ultrastructural study of development of hepatic necrosis induced by TNF-alpha and d-galactosamine. Dig Dis Sci 43 (1998) 887-892
152. Parent C., and Eichacker P.Q. Neutrophil and endothelial cell interactions in sepsis. The role of adhesion molecules. Infect Dis Clin North Am 13 (1999) 427-447
153. Singer G., Houghton J., Rivera C.A., Anthoni C., and Granger D.N. Role of LPS in the hepatic microvascular dysfunction elicited by cecal ligation and puncture in mice. J Hepatol 47 (2007) 799-806
154. Singer G., Urakami H., Specian R.D., Stokes K.Y., and Granger D.N. Platelet recruitment in the murine hepatic microvasculature during experimental sepsis: role of neutrophils. Microcirculation 13 (2006) 89-97
155. Croner R.S., Hoerer E., Kulu Y., Hackert T., Gebhard M.M., Herfarth C., et al. Hepatic platelet and leukocyte adherence during endotoxemia. Crit Care 10 (2006) R15
156. Czaja M., Xu J., and Alt E. Prevention of carbon tetrachloride-induced rat injury by soluble tumor necrosis factor receptor. Gastroenterology 108 (1995) 1849-1854
157. Kaplowitz N. Mechanisms of liver cell injury. J Hepatol 32 (2000) 39-47
158. Leist M., Gantner F., Bohlinger I., Germann P.G., and Tiegs G. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF requires transcriptional arrest. J Immunol 153 (1994) 1778-1787
159. Pfeffer K., Matsuyama T., Kundig T.M., Wakeham A., Kishiara K., and Shahinian A. Mice deficient in 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73 (1993) 457-467
160. Mita A., Hashikura Y., Tagawa Y., Nakayama J., Kawakubo M., and Miyagawa S. Expression of Fas ligand by hepatic macrophages in patients with fulminant hepatic failure. Am J Gastroenterol 100 (2005) 2551-2559
161. Tagawa Y., Kakuta S., and Iwakura Y. Involvement of Fas/Fas ligand system-mediated apoptosis in the development of concanavalin A-induced hepatitis. Eur J Immunol 28 (1998) 4105-4113
162. Malhi H., Gores G.J., and Lemasters J.J. Apoptosis and necrosis in the liver: a tale of two deaths?. Hepatology 43 (2006) S31-S44
163. Eksteen B., Afford S.C., Wigmore S.J., Holt A.P., and Adams D.H. Immune-mediated liver injury. Semin Liver Dis 27 (2007) 351-366
164. Ryo K., Kamogawa Y., Ikeda I., Yamauchi K., Yonehara S., Nagata S., et al. Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure. Am J Gastroenterol 95 (2000) 2047-2055
165. Zhang H., Cook J., Nickel J., Yu R., Stecker K., Myers K., et al. Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis. Nat Biotechnol 18 (2000) 862-867
166. Laskin D.L., and Laskin J.D. Role of macrophages and inflammatory mediators in chemically induced toxicity. Toxicology 160 (2001) 111-118
167. Winwood P.J., and Arthur M.J. Kupffer cells: their activation and role in animal models of liver injury and human liver disease. Semin Liver Dis 13 (1993) 50-59
168. Jaeschke H., and Hasegawa T. Role of neutrophils in acute inflammatory liver injury. Liver Int 26 (2006) 912-919
169. Liu Z.X., Han D., Gunawan B., and Kaplowitz N. Neutrophil depletion protects against murine acetaminophen hepatotoxicity. Hepatology 43 (2006) 1220-1230
170. Laskin D.L., Gardner C.R., Price V.F., and Jollow D.J. Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology 21 (1995) 1045-1050
171. Boess F., Bopst M., Althaus R., Polsky S., Cohen S., Eugster H.-P., et al. Acetamiophen hepatoxicity in tumour necrosis factor/lymphotoxin-alpha gene knock out mice. Hepatology 27 (1998) 1021-1029
172. Simpson K.J., Lukacs N.W., McGregor A.H., Harrison D.J., Strieter R.M., and Kunkel S.L. Inhibition of tumour necrosis factor alpha does not prevent experimental-induced hepatic necrosis. J Pathol 190 (2000) 489-494
173. Masubuchi Y., Bourdi M., Reilly T.P., Graf M.L., George J.W., and Pohl L.R. Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. Biochem Biophys Res Commun 304 (2003) 207-212
174. Li B., Sun R., Wei H., Gao B., and Tian Z. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism. Hepatology 43 (2006) 1211-1219
175. Lozano J.M., Collado J.A., Medina T., and Muntane J. Protection against liver injury by PGE1 or anti-TNF-alpha is associated with a reduction of TNF-R1 expression in hepatocytes. Scand J Gastroenterol 38 (2003) 1169-1175
176. Lozano J.M., Padillo J., Montero J.L., Pena J., De la Mata M., and Muntane J. Immunomodulatory activity of TNF-alpha during acute liver injury induced by d-galactosamine and its protection by PGE1 in rats. Int Immunopharmacol 3 (2003) 197-207
177. Muntane J., Rodriguez F.J., Segado O., Quintero A., Lozano J.M., Siendones E., et al. TNF-alpha dependent production of inducible nitric oxide is involved in PGE(1) protection against acute liver injury. Gut 47 (2000) 553-562
178. Akerman P., Cote P., Yang S.Q., McClain C., Nelson S., Bagby G.J., et al. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol 263 (1992) G579-G585
179. Webber E.M., Bruix J., Pierce R.H., and Fausto N. Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology 28 (1998) 1226-1234
180. Blindenbacher A., Wang X., Langer I., Savino R., Terracciano L., and Heim M.H. Interleukin 6 is important for survival after partial hepatectomy in mice. Hepatology 38 (2003) 674-682
181. Klein C., Wustefeld T., Assmus U., Roskams T., Rose-John S., Muller M., et al. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury. J Clin Invest 115 (2005) 860-869
182. Aihaiti X., Hayamizu K., Oishi K., Yoshimitsu M., Itamoto T., and Asahara T. Facilitation of survival in a rat fulminant hepatic failure model by combination therapy using recombinant G-CSF and tacrolimus. J Interferon Cytokine Res 26 (2006) 226-234
183. Oishi K., Hayamizu K., Aihaiti X., Itamoto T., Arihiro K., and Asahara T. G-CSF-induced evacuation of sinusoidal NK cells and the facilitation of liver regeneration in a partial hepatectomy. Cytokine 34 (2006) 66-75
184. Uchida K., Sakaida I., Hironaka K., Kayano K., and Okita K. Preventive effect of FK 506 (tacrolimus hydrate) on experimentally induced acute liver injury in rats. Dig Dis Sci 45 (2000) 1996-2001
185. Henderson N.C., Pollock K.J., Frew J., Mackinnon A.C., Flavell R.A., Davis R.J., et al. Critical role of c-jun (NH2) terminal kinase in paracetamol-induced acute liver failure. Gut 56 (2007) 982-990
186. Song E., Lee S.K., Wang J., Ince N., Ouyang N., Min J., et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 9 (2003) 347-351
187. Zender L., Hutker S., Liedtke C., Tillmann H.L., Zender S., Mundt B., et al. Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci USA 100 (2003) 7797-7802